Report Description
A recent market
intelligence report that is published by Data Insights Partner on the
global IgM/IgG Rapid Test Kits Market makes an
offering of in-depth analysis of segments and sub-segments in the regional and
international IgM/IgG Rapid Test Kits Market. The research also emphasizes on the impact of restraints,
drivers, and macro indicators on the regional and global IgM/IgG
Rapid Test Kits Market over the short as well
as long period of time. A detailed presentation of forecast, trends, and dollar
values of global IgM/IgG Rapid Test Kits Market is offered. In accordance with the report, the global
IgM/IgG Rapid Test Kits Market is projected to
expand by healthy CAGR over the period
of forecast.
Market Insight, Drivers, Restraints&
Opportunity of the Market:
Current laboratory testing for COVID-19 and its causative pathogen,
SARS-CoV-2, involves using real-time reverse transcription polymerase chain
reaction (rRT-PCR) on upper or lower respiratory tract samples. This testing is
currently available through the Minnesota Department of Health (MDH) Public
Health Laboratory and various commercial labs for patients in certain priority
testing categories.
The U.S. Food and Drug
Administration (FDA) recently granted an Emergency Use Authorization (EUA) for
a rapid serological test for SARS-CoV-2 from Cellex, specifically for the
detection of anti-SARS-CoV-2 IgG and IgM antibodies in blood. An EUA does not
mean that a test is FDA cleared or approved. This IgG/IgM assay is only
authorized for use in laboratories certified under CLIA (Clinical Laboratory
Improvement Amendments) to perform moderate- and highcomplexity tests. Many
other commercial manufacturers have notified the FDA that they have validated
and are distributing various types of serological tests for use in the
management of COVID-19, without pursuing or receiving authorization from the
FDA. FDA has also warned of companies marketing unauthorized and fraudulent
home COVID-19 testing kits.
Segment Covered:
This market intelligence
report on the global IgM/IgG Rapid Test Kits Market encompasses market segments based on Type of Serological
Test , Application and country.
By Type
of Serological Test the global IgM/IgG Rapid Test Kits Market has been divided
into:
·
RDT(Rapid
Diagnostic Test)
·
ELISA(Enzyme-linked
Immunosorbent Aassay)
·
Neutralization
Assay
By
Application the global IgM/IgG Rapid Test Kits Market has been divided into:
·
Hospital
·
Special Clinic
·
Research
Institutions
By country/region,
the global IgM/IgG Rapid Test Kits Market has been divided into:
·
North America
(the U.S., Canada),
·
Latin America
(Brazil, Mexico, Argentina and other countries),
·
Europe (Germany,
France, the U.K., Spain, Italy, Russia, and other countries),
·
Asia Pacific
(India, Japan, China, Australia and New Zealand and other countries),
·
Middle East and
Africa (GCC, South Africa, Israel and Other countries).
Profiling of Market
Players:
This business
intelligence report offers profiling of reputed companies that are operating in
the market. Companies such as:
·
Cellex
·
RayBiotech
·
Biopanda
·
BioMedomics
·
GenBody
·
SD Biosensor
·
Advaite
·
Premier Biotech
·
Epitope
Diagnostics
·
CTK Biotech
·
Creative
Diagnostics
·
Eagle
Biosciences
·
Sure Biotech
·
Sugentech
·
Sensing self
·
Euroimmun AG
·
PharmACT
·
Liming Bio
·
Beijing Wantai
·
Livzon
Diagnostics
·
Shenzhen BioEasy
Biotechnology
·
Orient Gene
Biotech
·
INNOVITA
·
Dynamiker
·
Guangzhou Wonfo
Bio-Tech
others have been
profiled into detail so as to offer a glimpse of the market leaders. Moreover,
parameters such as IgM/IgG Rapid Test Kits Market related investment & spending and developments by
major players of the market are tracked in this global report.
Report Highlights:
In-depth
analysis of the micro and macro indicators, market trends, and forecasts of
demand is offered by this business intelligence report. Furthermore, the report
offers a vivid picture of the factors that are steering and restraining the
growth of this market across all geographical segments. In addition to that, IGR-Growth
Matrix analysis is also provided in the report so as to share insight of the
investment areas that new or existing market players can take into consideration.
Various analytical tools such as DRO analysis, Porter's five forces analysis
has been used in this report to present a clear picture of the market. The
study focuses on the present market trends and provides market forecast from
the year 2020-2028. Emerging trends that would shape the market demand in the
years to come have been highlighted in this report. A competitive analysis in
each of the geographical segments gives an insight into market share of the
global players.
Salient Features:
Ø
This study offers
comprehensive yet detailed analysis of the IgM/IgG
Rapid Test Kits Market, size of the
market (US$ Mn and Mn Units), and Compound Annual Growth Rate (CAGR (%)) for
the period of forecast: 2020-2028, taking into account 2019 as the base year
Ø
It explains upcoming
revenue opportunities across various market segments and attractive matrix of
investment proposition for the said market
Ø
This market
intelligence report also offers pivotal insights about various market opportunities,
restraints, drivers, competitive market strategies of leading market players,
emerging market trends, and regional outlook
Ø
Profiling of
key market players in the world IgM/IgG Rapid Test Kits Market is done by taking into account various parameters such
as company strategies, distribution strategies, product portfolio, financial
performance, key developments, geographical presence, and company overview
Ø
The data of
this report would allow management authorities and marketers of companies alike
to take informed decision when it comes to launch of Type of models, government
initiatives, marketing tactics and expansion, and technical up gradation
Ø
The world
market for IgM/IgG Rapid Test Kits caters to the needs of various stakeholders pertaining to this
industry, namely suppliers, manufacturers, investors, and distributors for IgM/IgG
Rapid Test Kits Market. The research
also caters to the rising needs of consulting and research firms, financial
analysts, and new market entrants
Ø
Research
methodologies that have been adopted for the purpose of this study have been
clearly elaborated so as to facilitate better understanding of the reports
Ø
Reports have
been made based on the guidelines as mandated by General Data Protection
Regulation
Ø
Ample number
of examples and case studies have been taken into consideration before coming
to a conclusion
Reasons to buy:
v
Identify
opportunities and plan strategies by having a strong understanding of the investment
opportunities in the IgM/IgG Rapid Test Kits Market.
v
Identification
of key factors driving investment opportunities in the IgM/IgG Rapid
Test Kits Market
v
Facilitate
decision-making based on strong historic and forecast data
v
Position
yourself to gain the maximum advantage of the industry’s growth potential
v
Develop
strategies based on the latest regulatory events
v
Identify key
partners and business development avenues
v
Respond to
your competitors’ business structure, strategy and prospects
v
Identify key
strengths and weaknesses of important market participants